Publication Name	World Journal of Gastroenterology
Manuscript ID	5497
Country	China

Received	2013-09-11 09:14
Peer-Review Started	2013-09-13 15:45
To Make the First Decision	2013-09-27 17:01
Return for Revision	2013-09-29 20:12
Revised	2013-10-04 15:34
Second Decision	2013-10-17 14:51
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2013-10-18 08:10
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor	2013-11-07 21:56
Typeset the Manuscript	2013-11-27 09:48
Publish the Manuscript Online	2013-12-18 10:39

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Review
Article Title	Cross-talk between the thyroid and liver: A new target for nonalcoholic fatty liver disease treatment
Manuscript Source	Invited Manuscript
All Author List	Yue-Ye Huang, Aaron M Gusdon and Shen Qu
Funding Agency and Grant Number
Corresponding Author	Shen Qu, Professor, Department of Endocrinology and Metabolism, Shanghai 10th People's Hospital, School of Medicine, Tongji University, No301 Middle Yanchang Road, Shanghai 200072, China. qushencn@hotmail.com
Key Words	Thyroid hormone; Thyroid hormone receptor; Nonalcoholic fatty liver disease; Obesity
Core Tip	The clinical findings that nonalcoholic fatty liver disease (NAFLD) patients have more prevalence of subclinical hypothyroidism and patients with hypothyroidism may develop fatty liver give the evidence that dyslipidemia and fatty liver have some relationship with thyroid dysfunction, and thyroid hormone and its receptor may be a therapeutic target for NAFLD. We review here that thyroid hormone and TR are a potential target for pharmacologic treatments that can benefit NAFLD patients a lot.
Publish Date	2013-12-18 10:39
Citation	Huang YY, Gusdon AM, Qu S. Cross-talk between the thyroid and liver: A new target for nonalcoholic fatty liver disease treatment. World J Gastroenterol 2013; 19(45): 8238-8246
URL	http://www.wjgnet.com/1007-9327/full/v19/i45/8238.htm
DOI	http://dx.doi.org/10.3748/wjg.v19.i45.8238

Full Article (PDF)	WJG-19-8238.pdf
Manuscript File	5497-Review.docx
Answering Reviewers	5497-Answering reviewers.pdf
Copyright License Agreement	5497-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	5497-Language certificate.pdf
Peer-review Report	5497-Answering reviewers.pdf
Scientific Editor Work List	5497-Scientific editor work list.doc